Filing Details

Accession Number:
0001232524-16-000281
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-26 17:02:42
Reporting Period:
2016-05-24
Filing Date:
2016-05-26
Accepted Time:
2016-05-26 17:02:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1536639 Seamus Mulligan Connaught House, 1 Burlington Rd, Fl. 4
Dublin 4 L2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2016-05-24 1,400 $148.65 1,101,179 No 4 S Direct
Ordinary Shares Disposition 2016-05-24 11,888 $149.64 1,089,291 No 4 S Direct
Ordinary Shares Disposition 2016-05-24 9,954 $150.72 1,079,337 No 4 S Direct
Ordinary Shares Disposition 2016-05-24 4,726 $151.51 1,074,611 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.18 to $149.14. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  3. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $149.18 to $150.17. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  4. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $150.18 to $151.17. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  5. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $151.18 to $151.77. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.